The first decade with the Swedish prescribed drug register–a systematic review of the output in the scientific literature SM Wallerstedt, B Wettermark, M Hoffmann Basic & clinical pharmacology & toxicology 119 (5), 464-469, 2016 | 221 | 2016 |
The Nordic prescription databases as a resource for pharmacoepidemiological research—a literature review B Wettermark, H Zoëga, K Furu, M Korhonen, J Hallas, M Nørgaard, ... Pharmacoepidemiology and drug safety 22 (7), 691-699, 2013 | 205 | 2013 |
Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance B Godman, B Wettermark, M Hoffmann, K Andersson, A Haycox, ... Expert review of pharmacoeconomics & outcomes research 9 (1), 65-83, 2009 | 184 | 2009 |
Dabigatran–a case history demonstrating the need for comprehensive approaches to optimize the use of new drugs RE Malmström, BB Godman, E Diogene, C Baumgärtel, M Bennie, ... Frontiers in pharmacology 4, 39, 2013 | 119 | 2013 |
Changes in women's attitudes towards and use of hormone therapy after HERS and WHI M Hoffmann, M Hammar, KI Kjellgren, L Lindh-Åstrand, J Brynhildsen Maturitas 52 (1), 11-17, 2005 | 104 | 2005 |
Women's conception of the menopausal transition–a qualitative study L Lindh‐Åstrand, M Hoffmann, M Hammar, KI Kjellgren Journal of Clinical Nursing 16 (3), 509-517, 2007 | 103 | 2007 |
Pharmacokinetics of nicotine in kidney failure L Molander, A Hansson, E Lunell, L Alainentalo, M Hoffmann, R Larsson Clinical Pharmacology & Therapeutics 68 (3), 250-260, 2000 | 66 | 2000 |
High incidence of antibiotic resistance among bacteria in 4 intensive care units at a university hospital in Sweden HÅK Hanberger, M Hoffmann, S Lindgren, LE Nilsson Scandinavian journal of infectious diseases 29 (6), 607-614, 1997 | 58 | 1997 |
14-year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity-an independent risk factor for both BSI and mortality M Holmbom, CG Giske, M Fredrikson, Å Östholm Balkhed, C Claesson, ... PLoS one 11 (11), e0166527, 2016 | 53 | 2016 |
Utilization and costs of lipid modifying therapies following health technology assessment for the new reimbursement scheme in Sweden B Pettersson, M Hoffmann, P Wändell, LÅ Levin Health policy 104 (1), 84-91, 2012 | 47 | 2012 |
The prevalence of symptoms possibly related to the climacteric in pre-and postmenopausal women in Linköping, Sweden C Jansson, S Johansson, L Lindh-Åstrand, M Hoffmann, M Hammar Maturitas 45 (2), 129-135, 2003 | 41 | 2003 |
Attitudes towards the menopause and hormone therapy over the turn of the century L Lindh-Åstrand, J Brynhildsen, M Hoffmann, S Liffner, M Hammar Maturitas 56 (1), 12-20, 2007 | 37 | 2007 |
Hot flushes, hormone therapy and alternative treatments: 30 years of experience from Sweden L Lindh-Åstrand, M Hoffmann, M Hammar, AC Spetz Holm Climacteric 18 (1), 53-62, 2015 | 33 | 2015 |
The right drug, but from whose perspective? A framework for analysing the structure and activities of drug and therapeutics committees M Hoffmann European journal of clinical pharmacology 69, 79-87, 2013 | 33 | 2013 |
Hormone therapy might be underutilized in women with early menopause L Lindh-Åstrand, M Hoffmann, L Järvstråt, M Fredriksson, M Hammar, ... Human Reproduction 30 (4), 848-852, 2015 | 29 | 2015 |
Phases in development of an interactive mobile phone-based system to support self-management of hypertension I Hallberg, C Taft, A Ranerup, U Bengtsson, M Hoffmann, S Höfer, ... Integrated blood pressure control, 19-28, 2014 | 28 | 2014 |
Hormone replacement therapy in the menopause: Structure and content of risk talk M Hoffmann, L Lindh-Åstrand, J Ahlner, M Hammar, KI Kjellgren Maturitas 50 (1), 8-18, 2005 | 25 | 2005 |
Generic pregabalin: current situation and implications for health authorities, generics and biosimilars manufacturers in the future B Godman, M Wilcock, A Martin, S Bryson, C Baumgärtel, T Bochenek, ... Generics and Biosimilars Initiative Journal 4 (3), 125-135, 2015 | 24 | 2015 |
Risk talk: rhetorical strategies in consultations on hormone replacement therapy M Hoffmann, P Linell, L Lindh-Åstrand, K Kjellgren Health, Risk & Society 5 (2), 139-154, 2003 | 23 | 2003 |
Surveillance of antibiotic resistance in ICUs in southeastern Sweden CM Erlandsson, H Hanberger, I Eliasson, M Hoffmann, B Isaksson, ... Acta anaesthesiologica scandinavica 43 (8), 815-820, 1999 | 22 | 1999 |